- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07609316
Effectiveness of a Culturally Adapted Online Education Program (iSupport-Korea) for Family Caregivers of People With Dementia
Effectiveness of a Culturally Adapted Online Education Program (iSupport-Korea) for Family Caregivers of People With Dementia: A Randomized Controlled Trial
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
BACKGROUND Dementia is a major public health concern that is rapidly increasing alongside population aging and requires long-term care due to its progressive nature. In Korea, one of the fastest-aging countries in the world, both the prevalence of dementia and the number of family caregivers are continuously increasing.
In the Korean context, family members often serve as the primary caregivers for people with dementia, and they experience multifaceted burdens, including physical fatigue, emotional stress, social isolation, and lack of caregiving skills. These burdens may lead to deterioration in caregivers' health, reduced quality of life for people with dementia, earlier institutionalization, and increased societal costs.
The World Health Organization (WHO) developed iSupport, an evidence-based online education program for family caregivers of people with dementia. However, the program is based on an international standard and may not fully reflect the sociocultural context and caregiving environment in Korea. Therefore, there has been a growing need for cultural adaptation beyond simple translation.
In addition, family caregivers often face limitations in participating in face-to-face education due to the long hours required for caregiving, highlighting the need for accessible digital interventions that can be used regardless of time and place.
STUDY DESIGN This study is a randomized controlled trial with a two-arm parallel-group design. A total of 160 family caregivers of people with dementia will be recruited through dementia care centers. Participants who meet the eligibility criteria and provide informed consent will be randomly assigned in a 1:1 ratio to either the intervention group or the control group. Randomization will be performed using a computer-generated random number sequence, with stratification by recruitment site to minimize potential imbalance across centers.
INTERVENTION Participants in the intervention group will receive access to the iSupport-Korea online program for 2 months, a self-directed digital intervention covering key aspects of dementia caregiving. The program is delivered via a web-based platform and can be used at the participant's own pace. The control group will access publicly available dementia-related informational websites and continue usual care, with access to iSupport-Korea offered after study completion.
DATA COLLECTION Data will be collected at three time points: baseline (prior to intervention), 2 months (post-intervention), and 4 months (follow-up). All data will be collected using self-administered online questionnaires. Participants will receive secure links to complete the surveys using their personal devices. In cases where online participation is not feasible, alternative arrangements may be provided to facilitate data collection.
STATISTICAL ANALYSIS The effectiveness of the intervention will be evaluated by comparing changes in outcome variables between the intervention and control groups over time. Repeated measures analysis will be conducted to assess the main effects of group and time, as well as group-by-time interaction effects. Additional analyses may be conducted to adjust for baseline differences and to account for missing data where appropriate.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: JINSOL SON
- Telefonnummer: +8242-580-8407
- E-Mail: jinsoleei21@gmail.com
Studienorte
-
-
Jung-gu, Daejeon
-
Daejeon, Jung-gu, Daejeon, Südkorea, 35015
- Rekrutierung
- College of Nursing, Chungnam National University
-
Kontakt:
- JINSOL SON
- Telefonnummer: +8242-580-8407
- E-Mail: jinsoleei21@gmail.com
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Adults aged 19 years or older
- Family caregivers currently providing care for a person diagnosed with dementia
- Informal caregivers such as spouse, children, or relatives
- Living with the person with dementia or providing regular care even if not cohabiting
- Able to read and understand Korean and communicate in Korean
- Able to use digital devices (e.g., smartphone, tablet, or computer) to access an online program
- Willing to provide informed consent and participate in the study
Exclusion Criteria:
- Not currently providing direct care to a person with dementia
- Participating in another dementia caregiver intervention or similar study
- Having severe cognitive impairment, psychiatric illness, or communication difficulties that limit participation
- Having severe visual or hearing impairment that interferes with program use
- Unable to complete follow-up assessments during the study period
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: iSupport-Korea Group
Participants will receive access to the iSupport-Korea program for 2 months.
|
iSupport-Korea is a culturally adapted online education and support program for family caregivers of people with dementia.
It is designed to enhance caregiver self-efficacy, coping strategies, and overall quality of life through a self-directed learning approach.
|
|
Aktiver Komparator: Dementia Information Website Group
Participants will be provided access to publicly available dementia-related informational websites, such as those provided by dementia care centers.
|
The control condition consists of access to publicly available dementia-related informational websites.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in subjective well-being (CarerQol-VAS)
Zeitfenster: Baseline, 2 months, and 4 months
|
Subjective well-being will be measured using the CarerQol-VAS, a visual analogue scale ranging from 0 to 10, with higher scores indicating greater well-being
|
Baseline, 2 months, and 4 months
|
|
Change in care-related quality of life (CarerQol-7D)
Zeitfenster: Baseline, 2 months, and 4 months
|
Care-related quality of life will be measured using the Carer-related Quality of Life instrument-7 Dimensions (CarerQol-7D), which assesses caregiving burden across seven dimensions.
Each dimension is rated on a 3-level scale (no, some, or a lot of problems), with higher scores indicating better care-related quality of life.
|
Baseline, 2 months, and 4 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in caregiver self-efficacy
Zeitfenster: Baseline, 2 months, and 4 months
|
Caregiver self-efficacy will be measured using a modified version of the Caregiver Self-Efficacy Scale (CSES), consisting of 10 items rated on a 0-10 Likert scale, with higher scores indicating greater caregiver self-efficacy.
|
Baseline, 2 months, and 4 months
|
|
Change in family decision-making self-efficacy
Zeitfenster: Baseline, 2 months, and 4 months
|
Family decision-making self-efficacy will be measured using the 13-item Family Decision-Making Self-Efficacy Scale.
Items are rated on a 5-point Likert scale ranging from 1 to 5, with higher scores indicating greater confidence in healthcare-related decision-making.
|
Baseline, 2 months, and 4 months
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 202601-SB-038-01
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Demenz
-
Hospices Civils de LyonRekrutierungKlinische Demenzbewertung (CDR) aus der Analyse der Krankenakte | Clinical Dementia Rating (CDR) Persönliches Interview mit dem PatientenFrankreich
Klinische Studien zur iSupport-Korea
-
Sunway UniversityUniversity of Malaya; Sarawak General Hospital; Sarawak Heart Centre; University...RekrutierungMachbarkeits-Pilotstudie | Wohlbefinden der Pflegekraft | Subjektive Belastung der PflegekraftMalaysia
-
Kangbuk Samsung HospitalAbgeschlossenLaparoskopieKorea, Republik von
-
Universidade do PortoSuspendiertDepressive Symptome | Angstsymptome | Subjektive Belastung der PflegekraftPortugal
-
Inje UniversityAbgeschlossenDarmvorbereitung, Wirksamkeit, Verträglichkeit, SicherheitKorea, Republik von
-
Hyub HuhAbgeschlossen
-
Apimeds, Inc.AbgeschlossenArthrose des KniesVereinigte Staaten
-
Korea University Anam HospitalAbgeschlossenDarmkrebs | DickdarmadenomKorea, Republik von
-
KangWon National University HospitalUnbekanntDarmspiegelungKorea, Republik von
-
Rajavithi HospitalAbgeschlossenHilar Cholangiokarzinom | GallenobstruktionThailand
-
Eunah Cho, MDAbgeschlossenPostoperative GenesungKorea, Republik von